Report from the CVOT Summit 2021: new cardiovascular, renal, and glycemic outcomes. Science ShareTwitterFacebookXingLinkedin cardiovascular diseaseChronic kidney diseasediabetesGLP-1 receptor agonistHeart failureLiving guidelinesMineralocorticoid receptor antagonistObesitySGLT2 inhibitorTirzepatide You May Also Like Science 30. Januar 2023 Bioequivalence of macitentan and tadalafil given as fixed-dose combination or single-component tablets in healthy subjects. Science 30. Januar 2023 Midazolam microdosing applied in early clinical development for drug-drug interaction assessment. Science 30. Januar 2023 The effects of vilaprisan on the pharmacodynamics and pharmacokinetics of a combined oral contraceptive – A randomized controlled trial.
